Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

With its stock down 7.6% over the past three months, it is easy to disregard Pfizer (NYSE:PFE). We, however decided ...

Pfizer is facing some revenue pressures due to some higher Medicare discounts. Read more to see why I upgrade PFE stock from ...

Three supercharged income stocks -- sporting an average yield of 8.63% -- are perfectly positioned to fatten investors' ...

With volatility taking center stage since the beginning of the year, investing in the stock market isn’t as easy as it was.

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...